Skp2 Is Required for Incretin Hormone-Mediated β-Cell Proliferation

被引:27
|
作者
Tschen, Shuen-Ing [1 ]
Georgia, Senta [1 ]
Dhawan, Sangeeta [1 ]
Bhushan, Anil [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-KINASE; DEGRADATION; P27; EXPRESSION; P27(KIP1); GROWTH; CYCLE; MASS; HYPERINSULINEMIA; REGENERATION;
D O I
10.1210/me.2011-1119
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The glucoincretin hormone glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (Ex-4) promote beta-cell growth and expansion. Here we report an essential role for Skp2, a substrate recognition component of SCF (Skp, Cullin, F-box) ubiquitin ligase, in promoting glucoincretin-induced beta-cell proliferation by regulating the cellular abundance of p27. In vitro, GLP-1 treatment increases Skp2 levels, which accelerates p27 degradation, whereas in vivo, loss of Skp2 prevents glucoincretin-induced beta-cell proliferation. Using inhibitors of phosphatidylinositol 3-kinase and Irs2 silencing RNA, we also show that the effects of GLP-1 in facilitating Skp2-dependent p27 degradation are mediated via the Irs2-phosphatidylinositol-3 kinase pathway. Finally, we show that down-regulation of p27 occurs in islets from aged mice and humans, although in these islets, age-dependent accumulation of p16(Ink4a) prevent glucoincretin-induced beta-cell proliferation; however, ductal cell proliferation is maintained. Taken together, these data highlight a critical role for Skp2 in glucoincretin-induced beta-cell proliferation. (Molecular Endocrinology 25:2134-2143, 2011)
引用
收藏
页码:2134 / 2143
页数:10
相关论文
共 50 条
  • [41] Thyroid hormone-mediated cell proliferation in frog Meckel's cartilage is specified before neural crest migration.
    Rose, CS
    Johnson, AL
    AMERICAN ZOOLOGIST, 2001, 41 (06): : 1571 - 1572
  • [42] FBXW2 suppresses proliferation and invasion of lung cancer cells by targeting SKP2 and β-catenin
    Yang, Fei
    Sun, Yi
    MOLECULAR & CELLULAR ONCOLOGY, 2019, 6 (04)
  • [43] Epigenetic involvement of Alien/ESET complex in thyroid hormone-mediated repression of E2F1 gene expression and cell proliferation
    Hong, Wei
    Li, Jinru
    Wang, Bo
    Chen, Linfeng
    Niu, Wenyan
    Yao, Zhi
    Baniahmad, Aria
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 415 (04) : 650 - 655
  • [44] DNAJC5 promotes hepatocellular carcinoma cells proliferation though regulating SKP2 mediated p27 degradation
    Wang, Hailong
    Luo, Jiayu
    Tian, Xuesi
    Xu, Linlin
    Zhai, Zhenyu
    Cheng, Minzhang
    Chen, Limin
    Luo, Shiwen
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (06):
  • [45] Expression of SKP2 protein in non-small cell lung carcinoma
    Yang Chun-Lu
    Zhao Jun
    Zhao Su-Ying
    CHINESE JOURNAL OF CANCER RESEARCH, 2007, 19 (03) : 195 - 200
  • [46] p27 mediated cell cycle regulation appears independent of SKP2 expression in prostate and renal cancers
    Kallakury, BVS
    Sheehan, CE
    Karikehalli, S
    Kaur, P
    Rassaei, N
    Azumi, N
    Ross, JS
    MODERN PATHOLOGY, 2003, 16 (01) : 156A - 156A
  • [47] p27 mediated cell cycle regulation appears independent of skp2 expression in prostate and renal cancers
    Kallakury, BVS
    Sheehan, CE
    Karikehalli, S
    Kaur, P
    Rassaei, N
    Azumi, N
    Ross, JS
    LABORATORY INVESTIGATION, 2003, 83 (01) : 156A - 156A
  • [48] Overexpression of SKP2 Promotes the Radiation Resistance of Esophageal Squamous Cell Carcinoma
    Wang, Xiao-Chun
    Tian, Li-Li
    Tian, Jing
    Jiang, Xiao-Yan
    RADIATION RESEARCH, 2012, 177 (01) : 52 - 58
  • [49] A negatively charged amino acid in Skp2 is required for Skp2-Cks1 interaction and ubiquitination of p27Kip1
    Wang, W
    Ungermannova, D
    Chen, L
    Liu, XD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (34) : 32390 - 32396
  • [50] Expression of SKP2 Protein in Non-small Cell Lung Carcinoma
    杨春鹿
    赵君
    赵苏英
    Chinese Journal of Cancer Research, 2007, (03) : 195 - 200